Proactive Diagnostics: Funding, Investors & Team (Sep 2026)
The ground-breaking new Q-SENS technology from Proactive Diagnostics satisfies and surpasses all prerequisites to become a reliable molecular and immunoassay testing solution in peoples' homes or any other point of need for a variety of applications. With the help of our cutting-edge technology, we hope to upend the current central-lab testing paradigm and enable people to take charge of their health and well-being in a way that has never been possible before. The main features of our platform are as follows: - Central lab precision (sensitivity and specificity) - Rapid outcomes in 5 to 10 minutes - Accessibility - Simpleness - Multiplexing, which involves testing for up to 32 biomarkers simultaneously using a tiny amount of body material obtained in a minimally intrusive method (proteins, nucleic acids, and small molecules)
Proactive Diagnostics has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Nov 2022.
That round is below the $2.6M median round size for Hospitals and Health Care companies tracked on FundedIQ over the last two years.
Proactive Diagnostics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Proactive Diagnostics Funding Rounds
Proactive Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Proactive Diagnostics Funding Compared to Other Hospitals and Health Care Startups
Proactive Diagnostics' latest round of $2.0M is below the median round in Hospitals and Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Proactive Diagnostics in Hospitals and Health Care and Thousand Oaks
Companies Similar to Proactive Diagnostics
Designed by nurses for nurses, the platform combines hospital reviews, job placement services, a community…
For the healthcare sector, SendaRide offers Personalized, Concierge Non-Emergency Medical Transportation.…
Curious Learning is an organization that is dedicated to helping underprivileged children improve their…
Every day, clinical pharmacists employed at various hospitals search for identical answers to clinical…
At Medix Infusion, we are passionate about guiding patients through their medical infusion and injectable…
Clinical investigation is the cornerstone of contemporary medicine. Rigid scientific investigations on new…
Building the first B2B marketplace for mental health is Legion Health. Legion Health permits mental health…
Positive Development holds that both you and the world are capable of improvement. The Best Approach We're…
Founders and early employees from businesses like Google, Dropbox, Airbnb, and athenahealth, as well as…
Simuhealth is a platform that helps simulation centers run more efficiently. It brings together everything…
Holaglow offers personalized aesthetic medicine and cosmetic dermatology services.
Proactive Diagnostics Funding FAQs
What does Proactive Diagnostics do?
The ground-breaking new Q-SENS technology from Proactive Diagnostics satisfies and surpasses all prerequisites to become a reliable molecular and immunoassay testing solution in peoples' homes or any other point of need for a variety of applications. With the help of our cutting-edge technology, we hope to upend the current central-lab testing paradigm and enable people to take charge of their health and well-being in a way that has never been possible before. The main features of our platform are as follows: - Central lab precision (sensitivity and specificity) - Rapid outcomes in 5 to 10 minutes - Accessibility - Simpleness - Multiplexing, which involves testing for up to 32 biomarkers simultaneously using a tiny amount of body material obtained in a minimally intrusive method (proteins, nucleic acids, and small molecules)
How much funding has Proactive Diagnostics raised?
Proactive Diagnostics has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Nov 2022.
When did Proactive Diagnostics last raise funding?
Proactive Diagnostics' most recent funding round on record is an undisclosed round of $2.0M, announced in Nov 2022.
Who is the CEO of Proactive Diagnostics?
Reuven Duer is listed as CEO at Proactive Diagnostics.
Where is Proactive Diagnostics headquartered?
Proactive Diagnostics is based in Thousand Oaks, California, United States.
How many employees does Proactive Diagnostics have?
Proactive Diagnostics is in the 1-10 employee band.
How does Proactive Diagnostics' funding compare to other Hospitals and Health Care startups?
Proactive Diagnostics' latest round of $2.0M is below the $2.6M median round size for Hospitals and Health Care companies on FundedIQ across 18 tracked companies over the last two years.
About FundedIQ's Proactive Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Proactive Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.